{
    "id": "621e9aa13a8413c653000053",
    "question": "Are there roles for cohesin mutations in AML?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's consider the current understanding of cohesin and its role in cancer, particularly in Acute Myeloid Leukemia (AML). Cohesin is a protein complex involved in maintaining genome stability by ensuring proper chromosome segregation during cell division. Mutations in cohesin have been implicated in various cancers, including AML.\\n\\nStep 1: Review of cohesin's role in cancer\\nCohesin's primary function is to maintain sister chromatid cohesion, which is essential for accurate chromosome segregation. In cancer, mutations in cohesin can lead to loss of cohesion, resulting in chromosomal instability and aneuploidy.\\n\\nStep 2: Cohesin mutations in AML\\nResearch has shown that cohesin mutations are a common feature in a subset of AML patients. These mutations can lead to the development of leukemic stem cells, which are thought to be responsible for the persistence of the disease.\\n\\nStep 3: Clinical significance\\nCohesin mutations in AML have been associated with poor prognosis and reduced response to chemotherapy. Therefore, understanding the role of cohesin mutations in AML is crucial for developing new therapeutic strategies.\\n\\nConclusion\\nBased on the current evidence, there are indeed roles for cohesin mutations in AML, and further research is needed to fully understand their impact on the disease.\\n\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 40.56911540031433
}